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Procollagen C proteinases (pCPs) cleave type I to III procollagen C propeptides as a necessary step in
assembling the major fibrous components of vertebrate extracellular matrix. The protein PCOLCE1 (procol-
lagen C proteinase enhancer 1) is not a proteinase but can enhance the activity of pCPs 10-fold in vitro and
has reported roles in inhibiting other proteinases and in growth control. Here we have generated mice with null
alleles of the PCOLCE1 gene, Pcolce, to ascertain in vivo roles. Although Pcolce/ mice are viable and fertile,
Pcolce/ male, but not female, long bones are more massive and have altered geometries that increase
resistance to loading, compared to wild type. Mechanical testing indicated inferior material properties of
Pcolce/ male long bone, apparently compensated for by the adaptive changes in bone geometry. Male and
female Pcolce/ vertebrae both appeared to compensate for inferior material properties with thickened and
more numerous trabeculae and had a uniquely altered morphology in deposited mineral. Ultrastructurally,
Pcolce/ mice had profoundly abnormal collagen fibrils in both mineralized and nonmineralized tissues. In
Pcolce/ tendon, 100% of collagen fibrils had deranged morphologies, indicating marked functional effects in
this tissue. Thus, PCOLCE1 is an important determinant of bone mechanical properties and geometry and of
collagen fibril morphology in mammals, and the human PCOLCE1 gene is identified as a candidate for
phenotypes with defects in such attributes in humans.
Procollagen precursors of the major fibrillar collagen types I
to III contain N and C propeptides that are cleaved upon
secretion to yield mature triple-helical monomers that associ-
ate into fibrils. In particular, cleavage of the C propeptide has
seemed an important rate-limiting step in fibrillogenesis, as
monomers that retain C propeptides, unlike those which retain
N propeptides, are not incorporated into fibrils in fibrillogen-
esis assays (15, 31). C propeptides are cleaved by procollagen
C proteinase (pCP) activity provided by bone morphogenetic
protein 1 (BMP1) and related metalloproteinases (15, 20).
This activity is potentiated 10-fold by a secreted 55-kDa
glycoprotein, designated the pCP enhancer 1 (PCOLCE1) (19,
33). PCOLCE1 binds specifically to the type I procollagen C
propeptide and to the C telopeptide, which links the C propep-
tide to the triple-helical domain, and may act by inducing a
conformational change that renders procollagen a fitter sub-
strate for pCP cleavage (19, 27). PCOLCE1 comprises three
major protein domains (36): two CUB domains and a C-ter-
minal NTR domain. CUB (complement-Uegf-BMP1) domains
are thought to mediate protein-protein interactions in a broad
range of proteins with roles in development (8). Proteolytically
processed 34- to 36-kDa forms of PCOLCE1, composed solely
of the two CUB domains, are found in cell culture and retain
in vitro pCP-enhancing activity and the ability to bind type I
procollagen C propeptides (19, 36).
The C-terminal NTR (NETRIN) motif has homology with C-
terminal domains of the netrins; complement components C3, C4,
and C5; and the frizzled-related proteins and with N-terminal
domains of the TIMPs (tissue inhibitors of metalloproteinases)
(4). Relevant to the latter homology, the PCOLCE1 NTR do-
main has been identified as a non-TIMP MMP (matrix metallo-
proteinase) inhibitor secreted by tumor cells and, like the TIMPs,
may serve to inhibit more than one proteinase (28). Thus,
PCOLCE1 CUB and NTR domains may both contribute to net
formation of fibrous matrix, by potentiating fibrillogenesis and
inhibiting matrix-degrading proteinases, respectively. PCOLCE1
may serve additional roles, as disruption of the rat PCOLCE1
gene was reported to result in anchorage-independent growth of
cultured fibroblasts (26).
A more recently isolated protein with only 43% sequence iden-
tity with PCOLCE1 but with an identical domain structure (43)
has been shown to have pCP-enhancing activity levels similar to
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those of PCOLCE1 (33) and is designated PCOLCE2. Recently
both PCOLCE1 and -2 have been found to bind the triple-helical
portions of fibrillar collagens and to bind collagen fibrils in tissues
(33). However, it is presently unknown how these newly described
capabilities of the PCOLCEs might contribute to pCP enhance-
ment or whether PCOLCEs, like other collagen-binding proteins,
might contribute to the higher-order structure of collagen fibrils
in tissues and/or interactions of such fibrils with other matrix or
cell surface components. PCOLCE1 has a broad distribution of
expression in soft tissues and highest expression levels in ossified
bone, whereas PCOLCE2 expression is more restricted, primarily
to nonossified cartilage, heart, and eye. The apparent inverse
partitioning of PCOLCE1 and -2 expression to ossified and non-
ossified portions of developing bone, respectively, suggests differ-
ent roles for the two proteins in formation of this tissue.
Here, in a direct approach towards ascertaining in vivo roles of
PCOLCE1, we have generated mice with null alleles of the Pcolce
gene. The Pcolce/ phenotype demonstrates PCOLCE1 to
indeed be an in vivo enhancer of procollagen processing and, in
addition, a determinant of bone strength and geometry and in
vivo collagen fibril morphologies in mineralized and nonmineral-
ized tissues.
MATERIALS AND METHODS
Generation of mutant mice and MEFs. A replacement targeting vector was
generated by inserting genomic DNA fragments, isolated from a 129/SvJ mouse
library (Stratagene), into vector pPNT (38). A 2.7-kb 5 homology arm was
inserted between pPNT NotI and XhoI sites upstream of the neo cassette, and a
2.6-kb 3 homology arm was inserted between pPNT XbaI and BamHI sites
downstream of the cassette. In the final targeting vector, the neo cassette replaces
2.5 kb of genomic sequences, including the entire second and third Pcolce
exons. 129/SvJ embryonic stem (ES) cells were electroporated with NotI-linear-
ized targeting vector and subjected to selection in G418 and ganciclovir. Four
correctly targeted lines were identified by Southern blot assays of genomic DNA
restricted with HindIII or BamHI and separately hybridized to 5 or 3 external
probes, respectively. Southern blot analysis with a neo probe confirmed the
absence of rearrangements or random integrations (data not shown). ES cells
from three independently targeted cell lines were injected into C57BL/6 blasto-
cysts and implanted into pseudopregnant females at the Children’s Hospital
Research Foundation Transgenic Facility (Cincinnati, OH). Chimeras were
crossed with outbred Black Swiss mice (Taconic), and analysis of agouti offspring
by Southern blotting for the targeted allele found germ line transmission from
two of the independently targeted ES cell lines, leading to establishment of two
separate mouse lines with Pcolce null alleles. Wild-type, heterozygous, and ho-
mozygous individuals were identified within the two lines via PCR amplification
using internal neor primer 5-GATCAGGATGATCTGGACGAAGAGC-3
(forward) and primer 5-AGGATGTTGCCTGGGCACCTAGTGG-3 (re-
verse), corresponding to Pcolce intron IV sequences, to generate a 1-kb band
for identification of the null allele or using the same reverse primer but forward
primer 5-CGCTGAGACTCCATCCTTAATTCGC-3, corresponding to Pcolce
intron II sequences, for generating a 1.35-kb band for identification of the
wild-type allele. Mouse embryo fibroblasts (MEFs) were derived from 13.5-day-
postconception embryos, as described previously (16).
Nucleic acid analyses. Southern blotting was performed as described previ-
ously (37). For reverse transcription-PCR (RT-PCR), total RNA was isolated
from MEFs using Trizol (Invitrogen), and reverse transcription reactions were
performed as described previously (32). PCR amplifications were with Pcolce
exon 1 forward primer, 5-AACCTCCTTTCTGGGCCCATTCCT-3 (nucleo-
tides 61 to 84, GenBank accession no. NM_008788), and exon 6 reverse primer,
5-GGAGCTCGTTCCCTTCAGAAGAGA-3 (nucleotides 771 to 794). Gly-
ceraldehyde-3-phosphate dehydrogenase-specific primers have been described
elsewhere (32). PCR products were electrophoresed on agarose gels and visu-
alized with ethidium bromide.
Protein analyses. In Fig. 2A, 25 ng each of recombinant PCOLCE1 and
PCOLCE2 (prepared as described in reference 33) was run on the same gel and
transferred to the same membrane as 30 l conditioned medium (from 10 ml
total/10-cm culture dish) and the equivalent of 10% of the cell layer from the
corresponding dish. To obtain samples, confluent MEFs were washed three times
with phosphate-buffered saline (PBS) and incubated for 24 h in serum-free Dulbec-
co’s modified Eagle’s medium (DMEM) containing 40 g/ml soybean trypsin inhib-
itor (SBTI) (Sigma). After 24 h, conditioned media were harvested, and protease
inhibitors were added to final concentrations of 1 mM p-aminobenzoic acid, 1 mM
N-ethylmaleimide, and 1 mM phenylmethylsulfonyl fluoride. Cells were washed with
PBS, and cell layer proteins were extracted in hot sodium dodecyl sulfate (SDS)-
polyacrylamide sample buffer. Proteins were resolved by SDS-polyacrylamide gel
electrophoresis (PAGE), under reducing conditions on a 10% acrylamide gel, and
subjected to immunoblot analysis as previously described (33, 34).
To analyze type I collagen processing, long-term metabolic radiolabeling of
confluent MEF collagens was conducted as previously described (29). Briefly,
confluent MEFs were incubated for 20 h in DMEM, 10% fetal bovine serum
(FBS) (HyClone), 50 g/ml ascorbic acid, 100 g/ml SBTI at pH 7.0. Cell
cultures were then incubated for 4 h in depletion medium, consisting of
DMEM, 5% dialyzed FBS, 50 g/ml ascorbic acid, and 100 g/ml SBTI,
followed by radiolabeling in the same type of medium for 24 h with 30 Ci/ml
L-[2,3-3H]proline (NEN Life Sciences). Radiolabeled collagen forms were ob-
tained from conditioned medium and analyzed by reducing SDS-PAGE on 5%
acrylamide gels and autofluorography, as previously described (35). Pulse-chase
radiolabeling of collagen intermediates was performed as described above, ex-
cept that depleted cells were radiolabeled for 1 h with 50 Ci/ml L-[2,3-3H]
proline, at which time media were replaced with DMEM, 5% FBS, 100 g/ml
SBTI. Media were collected after a 9-h chase, and collagen forms were analyzed
by autofluorography, as described above.
Preparation and analysis of type V and type I collagen forms for Western blot
analysis were performed as previously described for analysis of type XI collagen
intermediates (29). Briefly, confluent MEFs were grown overnight in DMEM,
10% FBS, 50 g/ml ascorbic acid. Cells were switched to DMEM containing 1
ng/ml transforming growth factor 1 (R&D Systems), 40 g/ml SBTI, and 50
g/ml ascorbic acid, and 48 h later, media were collected and type V and I
collagen forms were prepared as described for type I procollagen forms (above).
Proteins were subjected to SDS-PAGE on reducing 5% acrylamide gels and then
to immunoblot analysis using antibodies specific for the pro-1(V) chain variable
domain (39), antibody LF-67 against the pro-1(I) C telopeptide (36) (kindly
provided by Larry W. Fisher, National Institutes of Health), and antibody against
the 2(V) C telopeptide (below), using previously described conditions (14, 23,
39). Rabbit polyclonal antibodies to murine pro-2(V) C-telopeptide sequences
were raised in rabbits against peptide GDIMGHYDENMPDPC, corresponding
to residues 1232 to 1245 of the published mouse pro-2(V) sequence (3) (ac-
cession number NP_031763) plus an additional cysteine for coupling to keyhole
limpet hemocyanin. The pro-2(V) antibodies were affinity purified on a column
of the same peptide, as previously described (23).
Immunofluorescence. Primary MEFs were plated in Lab Tek Chamber Slides
(Nalgene Nunc) at a density of 1  104 cells/well; grown to 80 to 90% confluence
in DMEM, 10% FBS; and then placed in DMEM, 10% FBS, 50 g/ml ascorbic
acid for 72 h. Subsequently, cells were washed for 5 min in PBS, incubated for 30
min on ice in 0.5 M acetic acid, and washed with PBS for an additional 5 min.
Cells were blocked for 30 min in PBS containing 5% normal goat serum, fol-
lowed by 1 h of incubation in the same blocking solution containing 1:200
dilutions of primary LF-67 rabbit antibodies against (I) C-telopeptide se-
quences or against (I) C-propeptide sequences (2) (kindly provided by Arthur
Veis, Northwestern University). Following three washes of 5 min each in PBS,
cells were blocked for an additional 30 min in 5% normal goat serum in PBS and
then incubated in the same blocking solution containing a 1:1,000 dilution of goat
anti-rabbit immunoglobulin G conjugated to Alexa 546 dye (Molecular Probes).
Cells were washed three times for 5 min each in PBS and then mounted in
Immu-Mount (Thermo Shandon), and coverslips were added. Images were cap-
tured using a Zeiss Axiophot II microscope.
Transmission electron microscopy. For ultrastructural analyses of flexor digi-
torum longus (FDL) tendon and femur, male hind limbs were harvested; fixed
for 15 min at room temperature in 4% paraformaldehyde, 2.5% glutaraldehyde,
0.1 M sodium cacodylate, pH 7.4, with 8.0 mM CaCl2 (5); and transferred to
fresh fixative for an additional 105 min on ice. Hind limbs were transported on
ice in 10% sucrose, 0.4% paraformaldehyde, 0.25% glutaraldehyde in 0.1 M
sodium cacodylate, pH 7.4, after which FDL tendons were dissected free from
surrounding tissues. For femoral analysis, left femora were freed of all soft tissue
and demineralized for 3 weeks at 4°C in PBS, pH 7.2, 0.5% paraformaldehyde,
10% EDTA prior to further processing. Samples were postfixed with 1% osmium
tetroxide and en bloc stained with uranyl acetate-50% ethanol. After dehydration
in an ethanol series, followed by propylene oxide, tissue samples were infiltrated
and embedded in a mixture of Embed 812, nadic methyl anhydride, dodecenyl
succinic anhydride, and DMP-30 (Electron Microscopy Sciences). Thin sections
VOL. 26, 2006 Pcolce: DETERMINANT OF BONE AND TENDON ULTRASTRUCTURE 239
 o
n
 Septem
ber 12, 2018 by guest
http://m
cb.asm
.org/
D
ow
nloaded from
 
were cut on an ultramicrotome and poststained with 2% aqueous uranyl acetate,
1% phosphotungstic acid, pH 3.2. Sections were examined at 120 kV using a
Tecnai 12 transmission electron microscope equipped with a 2 K Gatan Ultra-
scan US1000 2 K digital camera.
Specimens for micro-computed tomography (micro-CT) analysis and four-
point bending assays. Left femora and eighth caudal vertebrae were harvested from
8-week-old Pcolce-null mice (n 	 16 male, n 	 15 female) and their wild-type
littermates (n	 15 male, n	 15 female). Femora and vertebrae were cleaned of soft
tissue at harvest and stored frozen in lactated Ringer’s solution at 20°C.
Micro-CT evaluation. Left femora and eighth caudal vertebrae were scanned
and reconstructed at 18-m voxels using a cone beam micro-CT system (GE
Healthcare BioSciences, London, Ontario, Canada) to assess geometric and
morphological properties. The three-dimensional data set generated by mi-
cro-CT was arranged as a series of 18-m-thick slices, oriented along the long
axis of the bone in the femora and along the superior-inferior axis of the
vertebrae. A representative threshold was applied to each slice (21). Geometric
analyses were performed on transverse cross sections over a 3-mm middiaphyseal
segment in the femora and morphological analysis over two independent stan-
dardized volumes of trabecular bone in the proximal and distal ends of the
vertebrae. Each slice of the femora data was analyzed for cross-sectional area,
cortical thickness, and bending moment of inertia in the anterior-posterior di-
rection about the medial-lateral axis of the bone. Data from each femur were
averaged over the whole region of interest to provide representative values for
the entire three-dimensional middiaphysis. Two standardized volumes of trabec-
ular bone were segmented from the proximal and distal ends of the vertebral
bodies and analyzed for bone volume fraction, trabecular thickness, degree of
anisotropy, trabecular number, and trabecular spacing.
Mechanical properties. Whole-bone mechanical properties were determined
by loading the left femora to failure in four-point bending using a servohydraulic
testing machine (858 Mini Bionix II; MTS Systems, Eden Prairie, MN) at a
constant displacement rate of 0.5 mm/s. Femora were loaded in the anterior-
posterior direction so that the posterior side of the bone was in tension and the
anterior side was in compression. All four loading points were placed in contact
with the bone by adjusting heights of the upper two points independently.
Regions loaded in four-point bending corresponded to those measured by micro-
CT. Displacement was monitored using a linear variable differential transducer
(050 MHR; Lucas Schavitts, Hampton, VA), and load data were collected with
a load cell (Sensotec, Columbus, OH) in series with the actuator. Load and
displacement data were sampled at 2,000 Hz using the TestStar IIs system
(version 2.4; MTS, Eden Prairie, MN). Load-displacement curves were analyzed
for whole-bone yield load, ultimate load, stiffness, failure energy, and displace-
ment ratio (ultimate displacement/yield displacement) using MATLAB software
(version 7.0; The Mathworks Inc., Natick, MA). Bone tissue material properties
were predicted using geometric measures from micro-CT for each bone and data
from the mechanical tests. The predicted tissue elastic moduli and yield strength
were calculated using standard mechanics of materials equations. These equa-
tions predict inherent material properties of the extracellular matrix, assuming a
bending mode of failure.
Statistical analysis. Multivariate general linear models and nonparametric
tests were used to test for differences by genotype, with significance attributed to
P
 0.05. Male and female subgroups were tested in separate models. Subsample
analyses using nonparametric exact tests were employed for micro-CT evalua-
tion. Multivariate general linear models were used to test for differences in
mechanical properties. Independent sample t tests were used to analyze the
predicted material properties.
RESULTS
Targeting of the Pcolce gene. To characterize in vivo roles of
PCOLCE1, mouse lines with null alleles for the PCOLCE1
gene Pcolce were created. Towards this end, a replacement
targeting vector was constructed (Fig. 1A) in which a neor
expression cassette replaces 2.5 kb of genomic sequence in-
cluding the entire second and third Pcolce exons (109 and 259
bp, respectively), which together encode the more N-terminal
CUB domain. Deletion of these exons not only removes all
sequences encoding this domain but also creates a frameshift,
such that nothing downstream of the signal peptide is trans-
lated in the original frame, and only 21 amino acids down-
stream of the frameshift are translated in the new frame, prior
to a premature stop codon. Four correctly targeted lines were
identified by Southern blot analysis of genomic DNA (Fig. 1B),
followed by injection of ES cells into C57BL/6 blastocysts and
implantation into pseudopregnant females. Two independently
targeted ES cell lines gave rise to male chimeras that trans-
mitted the targeted allele to progeny, upon mating to Black
Swiss females, leading to establishment of two separate lines of
mice with Pcolce null alleles. Genotyping within the two lines
was via PCR amplification using a forward internal neor primer
and a reverse primer corresponding to Pcolce intron IV se-
quences, to generate a 1-kb band corresponding to the null
allele or using the same reverse primer but a forward primer
corresponding to Pcolce intron II sequences to generate a
1.35-kb band corresponding to the wild-type allele (Fig. 1C).
To assay for wild-type and mutant allele expression, wild-type,
/, and / MEF RNA was subjected to RT-PCR, using a
Pcolce exon 1 forward primer and an exon 6 reverse primer.
Although these primers produced a clearly detectable 734-bp
band, corresponding to the wild-type allele, in / and /
mouse samples (Fig. 1D), the same primers were unable to
generate a 366-bp band corresponding to mutant allele mRNA
from either / or / RNA (not shown). These results are
consistent with the probability that mRNA from the mutant
allele is rapidly degraded via nonsense-mediated decay and
that the mutant Pcolce allele is thus a true null allele.
Pcolce-null mice are viable and fertile. Heterozygotes de-
rived from the two different lines of ES cells were separately
interbred to produce homozygotes for each line, and genotypes
of offspring from heterozygote-to-heterozygote matings were
determined at weaning (3 weeks). The proportion of /
offspring is 25% in both lines, showing Pcolce-null animals to
be both viable and fertile, with an absence of gross abnormal-
ities detected upon external inspection. Necropsies were per-
formed by a veterinary pathologist on four Pcolce/ mice,
ranging in age from 1 to 1.5 years. Although myocardial de-
generation with fibrosis, ventral extravasation of intervertebral
disks, and mineralization of focal areas of connective tissue in
limbs were noted in some mutant mice, none of these condi-
tions were constant features in all four Pcolce/ mice. More-
over, aspects of these conditions were also noted in some age-
matched / controls.
Absence of PCOLCE1 results in reduced levels of processing
of C propeptides of the major fibrillar procollagens and of the
pro-2 chain of minor fibrillar collagen type V. MEFs derived
from embryos with null alleles have previously been employed
in analyzing molecular/cellular effects of gene ablations (12, 29,
32, 39). Since PCOLCE1 is expressed by MEFs (24), MEFs
were isolated from embryos with null Pcolce alleles, to deter-
mine effects of PCOLCE1 ablation on procollagen processing.
Prior to such studies, we tested for possible MEF PCOLCE2
expression, due to possible functional overlap in cells in which
PCOLCE1 and -2 are coexpressed. The possibility of such
overlap would clearly be an important consideration in inter-
preting assays of pCP function in Pcolce-null MEFs. As can be
seen in Fig. 2A, wild-type MEFs produce readily detectable
amounts of both PCOLCE1 and -2. Moreover, levels of ex-
pression appeared to be relatively high, given the strength of
signals from samples representing only 3% of 10 ml medium
and 10% of corresponding cell layers from 10-cm plates, com-
pared to signal strengths of 25 ng each of PCOLCE1 and -2
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standards (Fig. 2A). As previously reported by Xu et al. for
porcine trabecular meshwork and human fibroblasts (43), all
detectable MEF PCOLCE2 was found associated with cell
layers. In contrast, all detectable PCOLCE1 was in condi-
tioned medium (Fig. 2A), and none was associated with the cell
layer (not shown). Importantly, Pcolce/ heterozygous MEFs
were found to have reduced levels of secreted PCOLCE1 com-
pared to wild type, whereas PCOLCE1 was undetectable in
conditioned medium of Pcolce/ MEFs (Fig. 2A). Thus, ad-
ditional evidence is supplied that targeted Pcolce alleles in the
present study are true null alleles. In contrast to results with
PCOLCE1, PCOLCE2 levels were similar for cultured MEFs
of all three genotypes (Fig. 2A).
PCOLCE1, initially isolated due to its observed ability to
potentiate the activities of pCPs in vitro (1), is primarily de-
scribed in the literature as a pCP enhancer, due to this in vitro
activity. To examine whether PCOLCE1 is actually employed
as a pCP enhancer by cells, we next compared procollagen
processing in wild-type and Pcolce-null MEF cultures. As dem-
onstrated in an autofluorogram of 24-h-[3H]proline-labeled
material from conditioned MEF medium (Fig. 2B), processing
of type I procollagen is diminished in Pcolce/ MEF culture
FIG. 1. Targeted disruption of the Pcolce gene. (A) Structure of the targeting vector and Pcolce locus before and after homologous recom-
bination. Horizontal arrows mark start sites and direction of transcription of neor (shaded box) and tk (open box) cassettes. Hatched boxes
represent Pcolce exons. Black boxes represent a 554-bp 5 external probe and a 414-bp 3 external probe. B, BamHI; E, EcoRI; H, HindIII; S, SacI;
Sm, SmaI; X, XbaI. (B) Southern blots of HindIII- or BamHI-restricted genomic DNA from a clone of untargeted ES cells (68) and from a clone
of correctly targeted ES cells (82), hybridized to the 5 or 3 external probe, respectively. The 5 probe detected bands of 9.5 and 5.5 kb from the
wild-type (WT) and targeted alleles, respectively, while the 3 probe detected bands of 4 and 8 kb from the wild-type and targeted alleles,
respectively. Numbers at left of panels are molecular sizes in kilobases. (C) /, /, and / individuals were identified within the two mouse
lines via PCR amplification using an internal neor primer (forward) and a reverse primer corresponding to Pcolce intron IV sequences, to
generate a 1-kb band identifying the null allele, or using the same reverse primer but a forward primer corresponding to Pcolce intron II
sequences, to generate a 1.35-kb band identifying the wild-type (WT) allele. M, DNA size markers marked with sizes in kilobases.
(D) RT-PCR analysis of poly(A) RNA prepared from MEFs detected a 734-bp amplimer for / and / MEFs but no bands for /
MEFs. M, 100-bp marker ladder with the 1-kb marker corresponding to the topmost band visible in the figure. G3PDH, glyceraldehyde-
3-phosphate dehydrogenase.
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medium compared to wild-type and / MEF media, as evi-
denced by higher levels of procollagen and lower levels of
mature 1(I) and 2(I) chains. In a separate analysis of effects
of PCOLCE1 ablation on type I procollagen processing by
cells, MEFs were pulsed for 1 h with [3H]proline and chased
for 9 h with unlabeled medium, and samples from conditioned
media were then run on a long gel to separate different pro-
cessing intermediates. Processing intermediates pC(I) (which
retains N but not C propeptides) and pN(I) (which retains C
but not N propeptides) comigrate upon SDS-PAGE as a dou-
blet, as seen for wild-type MEF medium sample (Fig. 2C). In
contrast, although amounts of pC1(I) were increased in
Pcolce/ MEF medium sample compared to wild type, de-
tectable pN1(I) chains were absent. This result is consistent
with the conclusion that PCOLCE1 serves to specifically facil-
itate processing of the type I procollagen C propeptide in vivo.
Underscoring this specificity, processing of the type V procol-
lagen pN1(V) chain, the globular N-terminal domain of
which is cleaved in vitro and in vivo by BMP1 (39), is unaf-
fected in Pcolce/ MEF medium (Fig. 2D). The latter result
is consistent with results from in vitro biochemical assays in
which PCOLCE1 has been found to have no effect on process-
ing of the N propeptide of the pro-1(V) chain (reference 27
and data not shown). Thus, in vivo activity of PCOLCE1
enhances processing of the C propeptides of the major fibrillar
collagens but not processing of the N propeptides of either the
major fibrillar collagens or the minor fibrillar collagen pro-1(V)
chain. Processing of probiglycan and chordin, both of which are
processed in vitro and in vivo by BMP1 (29, 32), was also unaf-
fected in Pcolce/ MEF medium (data not shown), consistent
with results showing PCOLCE1 to have no effect on processing of
either chordin (15, 27, 30) or probiglycan (data not shown) in in
vitro assays.
The predominant form of type V procollagen is a heterotri-
mer comprising one pro-2(V) and two pro-1(V) chains.
Although the pro-1(V) C propeptides are cleaved by furin-
like proprotein convertases, the pro-2(V) C propeptides are
cleaved by BMP1-like proteinases (39). Thus, we examined
whether processing of pro-2(V) C propeptides is affected by
the absence of PCOLCE1. As can be seen (Fig. 2E, left panel),
FIG. 2. Pcolce/ MEFs are devoid of PCOLCE1 and have reduced processing of the C propeptides of procollagen types I and V. (A) Twenty-
five nanograms each of recombinant PCOLCE1 and -2 is compared by Western blotting to samples corresponding to 30 l medium and 10% of
the cell layer of 10-ml-medium/10-cm-culture-dish cultures of Pcolce/, Pcolce/, and Pcolce/ MEFs. (B) An autofluorogram of 24-h-
[3H]proline-radiolabeled material shows type I procollagen processing to be diminished in Pcolce/ MEF medium, compared to Pcolce/ and
Pcolce/ MEF media. (C) An autofluorogram of pulse (1-h)/chase (9-h) [3H]proline-radiolabeled MEF medium samples, run on a long
SDS-polyacrylamide gel to separate processing intermediates, shows increased and decreased amounts of pC1(I) and pN1(I), respectively, in
a Pcolce/ sample compared to wild type (/). (D and E) Western blotting shows that processing of pN1(V) to mature 1(V) chains is
unaffected (D) but that processing of pro-2(V) to pN2(V) chains is decreased (E, left panel) in Pcolce/ MEFs, compared to wild type (/).
The Western blot in the right panel of panel E compares processing of type I procollagen in the same samples used for analyzing type V procollagen
processing in the left panel of panel E and in panel D.
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processing of the pro-2(V) C propeptide is diminished in
Pcolce/ MEF cultures compared to wild type. The diminish-
ment, though slight, was reproducible over the course of three
independent experiments and is the first indication that
PCOLCE1 can enhance the processing of substrates other than
the major fibrillar procollagens.
Pcolce/ bone phenotype. As Pcolce is expressed at partic-
ularly high levels in developing bone (33) and since type I
collagen, a product of pCP activity, is the major structural
protein of bone, constituting 80% of bone protein (22), bone
was the first Pcolce/ tissue subjected to detailed examination
for abnormalities. Micro-CT and subsample analyses using
nonparametric exact tests showed significant differences be-
tween wild-type and Pcolce/ males in cross-sectional area,
cortical thickness, and bending moment of inertia. Average
cross-sectional representations of male cortical bone showed
that excess bone apposition occurred on Pcolce/ medial and
lateral periosteum (Fig. 3), with increased bending moment
(anterior-posterior), compared to wild-type male littermates.
These differences were highly statistically significant. In con-
trast, although Pcolce/ female femora consistently had in-
creased cross-sectional area and cortical thickness compared
to wild-type littermate female femora, these differences were
not statistically significant with the numbers of mice used. As
suggested by the disparate results in the separate female and
male analyses, the effect of genotype on the parameters of
interest differs by sex. This sex difference is statistically signif-
icant for cross-sectional area (P 
 0.0010), cortical thickness
(P 	 0.02), and bending moment y (P 	 0.001).
Multivariate general linear models of four-point bending data
were used to test for differences in whole-bone mechanical prop-
erties by genotype. Results revealed that male Pcolce/ mutants
had significantly greater yield load and stiffness than did litter-
mate controls, although there was no difference between the two
groups in displacement ratio (Table 1).
Predicted modulus and yield strength were calculated from
the mechanical testing and geometrical properties using stan-
dard mechanics of materials equations. Independent sample t
tests showed a significant difference in elastic modulus by ge-
notype in males but no significant difference in predicted
strength by genotype in males or females (Table 2). Male
Pcolce/ mutant femora had a lower predicted modulus than
did male wild-type femur, thus suggesting inferior material
properties of the Pcolce-null bone. These results suggest that
the changed geometry, leading to increased bending moment,
and the increased cross-sectional area of Pcolce/ male fem-
ora were sufficient compensation by the organism for the in-
ferior material properties of these bones, such that the bone
maintained its overall strength compared to those of wild-type
male littermate controls.
With respect to trabecular tissue in vertebral bodies, subsample
analyses using nonparametric exact tests showed significant dif-
ferences in bone volume fraction, trabecular thickness, and de-
gree of anisotropy (degree of spatial orientation) by genotype.
Both male and female Pcolce/ mice had a larger bone volume
fraction and thicker, disoriented trabeculae compared to litter-
mate controls (Table 3). Similar results were observed in the
proximal and distal regions of the vertebrae.
The ultrastructure of Pcolce/ male femora was next com-
pared to that of wild-type male control femora by transmission
electron microscopy. As can be seen in Fig. 4, the collagen fibrils
of male Pcolce/ femur show aberrant, fluted, or scalloped cross
sections (Fig. 4B), unlike the far more circular outlines of collagen
fibrils in wild-type male control femur (Fig. 4A). Longitudinal
views (Fig. 4C and D) show Pcolce/ femur collagen fibrils to
have irregular, broadened profiles, with some branching, and to
be somewhat reminiscent of longitudinal views of the “hiero-
glyphic” fibrils of Ehlers-Danlos syndrome type VIIC patients (9).
Pcolce/ soft tissue phenotype. Type I collagen is also a major
structural protein in most soft tissues. In tendon, characterized
by densely packed collagen fibrils organized as fibers parallel to
the tendon axis, it is the major structural component and is
responsible for the mechanical attributes of this tissue. As is
evident from transmission electron micrographs comparing 30-
day-postnatal Pcolce/ and wild-type tendon (Fig. 5A and B),
collagen fibrils in this tissue are also markedly affected by the
FIG. 3. Average cross-sectional representations of male cortical
bone. Cone beam micro-CT scanning showed male Pcolce/ null
(blue, n	 16) medial and lateral femoral periostea to have excess bone
apposition, with increased bending moment (medial-lateral) compared
to wild-type male littermates (magenta, n 	 15).
TABLE 1. Mechanical analyses by gender and genotypea
Gender Genotype Yield load(N)
Stiffness
(N/mm)
Displacement
ratio
Female Pcolce/ 20.9 (4.9) 214 (35) 3.00 (1.3)
WT b 20.9 (5.5) 207 (40) 2.88 (1.3)
Male Pcolce/ 25.9 (6.6) 256 (65) 2.62 (1.0)
WT 21.0 (5.8) 204 (43) 2.76 (1.1)
a Data are given as means (standard deviations). , significant (P  0.05).
b WT, wild type.
TABLE 2. Predicted material properties by gender and genotypea
Gender Genotype Modulus(MPa)
Yield strength
(MPa)
Female Pcolce/ 6,278 (703) 114 (22)
WT b 6,866 (923) 123 (19)
Male Pcolce/ 5,461 (972) 107 (9.9)
WT 6,758 (941) 113 (33)
a Data are given as means (standard deviations). , significant (P  0.05).
b WT, wild type.
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absence of PCOLCE1, with Pcolce/ fibrils showing fluted/
scalloped cross sections, in contrast to the smooth, circular
cross sections of wild-type tendon fibers. It is also notable that
100% of collagen fibrils in Pcolce/ tendon have abnormal
cross sections, suggesting pronounced effects on the mechani-
cal properties and function of Pcolce-null tendon.
Analyses towards understanding the mechanical basis of the
effects of PCOLCE1 ablation on tissue collagen fibrils. It is dif-
ficult to explain the various changes in collagen fibril morphology
in Pcolce/ bone and tendon on the basis of changes in kinetics
of the cleavage of the major fibrillar procollagen C propeptides
alone. Previously, it has been suggested that abnormal collagen
fibrils in embryos null for genes that encode pCPs can result from
incorporation of type I collagen pC monomers (which retain C
propeptides) into growing fibrils (29, 35). Since ablation of a pCP
enhancer might also result in the incorporation of type I collagen
pC forms into nascent fibrils, type I collagen fibrils deposited by
wild-type and Pcolce-null MEFs were assayed for possible reten-
tion of C propeptides and compared to those deposited by MEFs
from embryos doubly homozygous null for the Bmp1 gene, which
generates alternatively spliced RNAs for the two pCP metallo-
proteinases BMP1 and mTLD, and the Tll1 gene, which encodes
the related pCP mTLL1. As can be seen in Fig. 6, antibody
directed against the pro-1(I) chain C propeptide (2) clearly
reacted with collagen fibrils in Bmp1/Tll1 doubly null MEF
cultures but did not react with collagen fibrils in either
wild-type or Pcolce/ MEF cultures. Thus, although these
data support the contention that aberrant Bmp1/Tll1 doubly
null collagen fibrils contain monomers with retained C propep-
FIG. 4. Transmission electron micrographs of collagen fibril morphology in 4-week-postnatal Pcolce/ and wild-type (Pcolce/) left femora.
Unlike wild-type fibril cross sections (A), all mutant collagen fibrils have irregular scalloped profiles in cross section (B), whereas longitudinal views
of collagen fibrils (C and D) show Pcolce/ fibrils to have irregular, broadened profiles, with some branching.
TABLE 3. Distal vertebral geometric analyses by
gender and genotypea
Gender Genotype BVF TbTh (mm) DA
Female Pcolce/ 0.418 (0.04) 0.074 (0.01) 1.87 (0.12)
WT 0.366 (0.08) 0.063 (0.01) 1.99 (0.11)
Male Pcolce/ 0.519 (0.05) 0.071 (0.00) 1.76 (0.11)
WT 0.457 (0.06) 0.063 (0.01) 1.97 (0.10)
a Data are given as means (standard deviations). , significant (P  0.05).
Abbreviations: BVF, bone volume fraction; TbTh, trabecular thickness; DA,
degree of anisotropy; WT, wild type.
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tides, the same does not appear to be the case for Pcolce/
collagen fibrils.
The fluted cross-sectional profiles of Pcolce/ tendon collagen
fibrils are somewhat reminiscent of collagen fibril morphol-
ogies encountered in the same tissue in mice with null alleles for
genes encoding small leucine-rich proteoglycans (SLRPs), such as
decorin, lumican, and fibromodulin (10, 18). Such phenotypes,
together with analyses via in vitro fibrillogenesis assays (12, 40,
41), have indicated that at least some SLRPs regulate fibrillogen-
esis directly, via interactions with collagen monomers. To deter-
mine whether PCOLCE1 might also regulate fibrillogenesis by
interacting with collagen monomers via mechanisms similar to
those of SLRPs, increasing amounts of PCOLCE1 were added to
in vitro type I collagen fibrillogenesis assays. As can be seen in
Fig. 7A, PCOLCE1, like bovine serum albumin (BSA), had no
appreciable effect on the final turbidity of the reaction
(thought to reflect the lateral growth of fibrils) and only an
apparently small effect on the reaction rate. In contrast, the
mature SLRP decorin (mDcn; decorin minus the propeptide)
is seen to markedly reduce rates of fibrillogenesis and final
turbidity levels, as previously reported (12, 40), in a concen-
tration-dependent manner. Shapes of fibrillogenesis curves in
the presence of 30 g/ml and 100 g/ml BSA, PCOLCE1, and
decorin are superimposed for comparison in Fig. 7B. Shapes of
curves were reproducible for BSA, PCOLCE1, and decorin
over the course of five experiments. Thus, unlike SLRPs,
PCOLCE1 does not appear to have a marked effect on fibril-
logenesis via direct interactions with collagen monomers. This
is consistent with the results of Hulmes et al. (17), who previ-
ously found a protein fragment containing the two PCOLCE1
CUB domains to have no appreciable effect on morphology of
collagen fibrils formed in vitro.
DISCUSSION
Here, we have generated and characterized mice with null
alleles for the Pcolce gene, to define in vivo roles for the
protein PCOLCE1. Absence of PCOLCE1 resulted in a site-
specific, gender-specific phenotype that affected the material
properties and geometry of bone. Pcolce/ males appeared to
compensate for weaker cortical bone material by increasing the
size and modifying the cross-sectional shape of long bones,
such as femora. This increase and modification in geometrical
properties drove an increase in structural mechanical integrity.
Male Pcolce/ femora are thus somewhat reminiscent of the
femora of Mov13/ mice, which have one null allele for the
1(I) chain of type I collagen and serve as a model for osteo-
genesis imperfecta type I (OI type I) (7). The similarity is that
Mov13/ mice, like Pcolce/ males, compensate for inferior
cortical bone material properties by generating more massive
bone with altered geometry, thus maximizing the bending
strength/moment of inertia (6). Interestingly, although Pcolce/
female femora tended to have increased cross-sectional area
and cortical thickness compared to wild-type littermate female
femora, these differences were not statistically significant with
the numbers of mice used. The gender effect in cortical bone
may be physiologic in nature and due to availability of hor-
mones and/or cytokines. However, an exact determination for
the sex difference in cortical bone cannot be made from the
studies done thus far.
In contrast to cortical bone, the absence of PCOLCE1 ap-
peared to cause identical phenomena in male and female
Pcolce/ trabecular bone. Pcolce-null mice increased their
trabecular bone volume fraction by thickening trabeculae and
by adding more trabecular struts (data not shown). As in the
cortical bone of femora, the thickening and increased number
of struts in Pcolce/ trabecular bone may represent an at-
tempt to compensate for weaker material properties of the
bone. Interestingly, histograms of the gray-scale voxel values
from micro-CT (calibrated through the use of a standard phan-
tom during scanning) suggested that the mutant trabecular
bone might have an alteration in the morphology of the min-
eral being deposited. Thus, we are left with the exciting and
quite novel possibility that an alteration in the mineral-colla-
gen interaction is driving the reduced material properties of
Pcolce-null bone.
FIG. 5. Transmission electron micrographs of collagen fibril morphology in 30-day-postnatal Pcolce/ (A) and wild-type littermate (B) FDL
tendon cross sections. All mutant collagen fibrils have an irregular, scalloped appearance in contrast to the smooth circular cross sections of the
wild-type tendon fibrils.
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Further investigation at the tissue and ultrastructural level is
needed in order to verify the material properties of Pcolce/
bone and to characterize the molecular network of the collagen
and mineral crystals. However, Pcolce-null bone is clearly un-
like Mov13/ bone. Although Mov13/ and male Pcolce/
cortical bone both have inferior material properties compared
to wild type, Pcolce/ cortical bone, unlike Mov13/ bone
(shown to be representative of OI type I cortical bone), is not
“brittle.” Thus, although Mov13/ femora shatter by almost
simultaneous breakage at both cortices at maximum load (7)
and demonstrate little resistance to crack propagation, male
Pcolce/ femora, like those of the wild type, typically frac-
tured initially at a single cortical surface (the one in tension),
with propagation of the fracture along the medullary canal
(data not shown) and continued energy absorption until com-
plete failure. This difference indicates that the Pcolce/ bone
FIG. 6. Collagen fibrils of Bmp1/Tll1 doubly null, but not Pcolce-null, MEFs contain readily detectable levels of type I procollagen pro-1(I) C
propeptides. Wild-type, Pcolce-null, and Bmp1/Tll1 doubly null MEF cell layers were subjected to immunofluorescence staining, employing
antibodies directed against the C-telopeptide (11) or C-propeptide (2) region of the pro-1(I) chain.
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phenotype is not easily explainable by invoking the haploinsuffi-
ciency of type I collagen deposition that underlies the Mov13/,
OI type I phenotype.
If Mov13/ mice are models for OI type I, then what human
condition is mirrored by the Pcolce/ phenotype? Studies de-
signed to determine the material properties of Pcolce-null bone,
which may help suggest a human correlate of the phenotype,
and studies of the Pcolce-null molecular network of collagen
and mineral, which will provide insights into the mechanism
whereby PCOLCE1 influences collagen-mineral interactions,
are currently under way.
The fluted/scalloped appearance of bone and tendon colla-
gen fibrils in Pcolce-null mice is reminiscent of features found
in the tendons of mice with null alleles for some SLRP genes.
However, an important difference is that, unlike SLRP-defi-
cient mice, which generally acquire the fibril phenotype later in
FIG. 7. Testing for a possible role for PCOLCE1 in regulating type I collagen fibrillogenesis. (A) Different concentrations of PCOLCE1 are
compared to matched concentrations of mature decorin (mDcn; decorin minus the propeptide) (positive control) and BSA (negative control) for
possible effects in a fibrillogenesis assay of type I collagen, in which turbidity (measured at 450 nm) is primarily a measure of lateral growth of fibrils
(13), and duration of the lag phase at the beginning of the assay, during which there is no detectable change in turbidity, is thought to involve
primarily linear elongation of thin fibrils (13). (B) Type I collagen fibrillogenesis curves in the presence of 30 g/ml (left panel) or 100 g/ml (right
panel) BSA, PCOLCE1, and mDcn are superimposed for comparison. Collagen was 0.5 mg/ml in all assays.
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development (during periods of fibril growth from fusion of
intermediates), Pcolce/ mice demonstrate the fibril pheno-
type throughout development. The latter finding suggests that
the Pcolce/ phenotype results from dysfunctional regulation
of an early step in collagen fibrillogenesis. We also demon-
strate here that PCOLCE1 does not markedly modulate fibril-
logenesis in a direct manner similar to that of SLRPs. Thus,
since neither the absence of SLRP-type regulatory activity on
fibrillogenesis nor a mere diminution of collagen deposition
seems adequate for explaining the profound and varied effects
on collagen fibril morphology and the unique bone phenotype
in Pcolce/ mice, some other mechanism(s) must be sought.
An interesting possibility is that dysregulation of type V pro-
collagen processing, as demonstrated here by the decreased
processing rate of pro-2(V) C propeptides in the absence of
PCOLCE1, contributes to the abnormal fibrillogenesis seen in
Pcolce/ tissues. Previous studies have shown the low-abun-
dance collagen type V to regulate the lateral growth of het-
erotypic fibrils in which it is incorporated with the much more
abundant collagen type I (25). Moreover, the developmental
evidence herein for a PCOLCE1 regulatory role that occurs at
an early step in collagen fibrillogenesis conforms with previous
evidence that type V collagen can also regulate type I collagen
fibrillogenesis early in development, via a collagen fibril nucle-
ation event (42). Another possible mechanism contributing
to the Pcolce/ phenotype is suggested by the ability of
PCOLCE1 to bind assembled collagen fibrils in tissues (33)
and involves the possibility that PCOLCE1 associated with
such fibrils may normally affect their structure and/or stability
and/or interactions with other extracellular matrix compo-
nents. Such possibilities remain to be explored.
The Pcolce/ tendon phenotype differs from that of mice null
for SLRP genes in that 100% of Pcolce/ tendon fibrils have
aberrant profiles. Future studies will explore the functional con-
sequences of these aberrant collagen fibrils for Pcolce/ tendon
and will also explore the possibility of joint laxity, due to the
possibility of similar aberrant fibrils in ligamentous attachments.
Such studies should provide further insights into how such a
phenotype might present clinically for humans with abnormalities
of the orthologous PCOLCE1 gene.
It remains unknown to what extent effects of PCOLCE1
ablation in Pcolce-null mice and MEFs may be masked by
functional redundancy provided by PCOLCE2. PCOLCE1 and -2
show similar levels of pCP-enhancing activity in vitro, against
both procollagen types I and II, and the two proteins are
coexpressed in MEFs and heart and other tissues (33). How-
ever, the two proteins appear to have nonoverlapping expres-
sion domains in bone and cartilage, respectively (33), and al-
though PCOLCE1 and -2 are both secreted (33), PCOLCE2 is
retained by cell layers, whereas PCOLCE1 is not (33, 43). The
latter difference is likely to influence modes of activity and is
relevant to questions regarding extents of functional overlap
and to the question of whether PCOLCE2 is capable of dif-
fusing over sufficient distances to complement loss of
PCOLCE1 in tissues where the latter, but not the former, is
ordinarily expressed. Such questions will be addressed via gen-
erating and characterizing mice with disrupted alleles for the
PCOLCE2 gene Pcolce2. Moreover, intercrossing of mice with
Pcolce and Pcolce2 null alleles will produce progeny, some of
which are doubly homozygous null for both genes, thereby
removing any possible functional redundancy/overlap and al-
lowing determination of the full range of in vivo functions of
this class of mammalian gene products.
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